What’s more, compared with the model group, the mNSS scores in the BMSCs group decreased at day 10 after transplantation and the percentage of the infarct area decreased at day 5 and day 10 after transplantation, indicating that BMSCs transplantation may treat cerebral ischemia through increasing GFAP expression and promoting angiogenesis. The gene discussed is GFAP; the disease is Cerebral ischemia.